Antigen-Peptide-Transporter 2 DeficiencySymptoms, Doctors, Treatments, Advances & More
Learn About Antigen-Peptide-Transporter 2 Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Timothy Chan is a Radiation Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 31 years. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Antigen-Peptide-Transporter 2 Deficiency. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Gliomatosis Cerebri, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Chan is board certified in American Board Of Radiology, 2009.
Jefferson Health – Center One
Yan Zhang is a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Zhang is rated as an Advanced provider by MediFind in the treatment of Antigen-Peptide-Transporter 2 Deficiency. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Antigen-Peptide-Transporter 2 Deficiency, Severe Acute Respiratory Syndrome (SARS), Multiple Sclerosis (MS), Paroxysmal Supraventricular Tachycardia (PSVT), and Endoscopy. Dr. Zhang is currently accepting new patients.
St Petersburg Outpatient Care Center - University Of South Florida - Allergy & Immunology
Jolan Walter is a Pediatric Allergy and Immunologist practicing medicine in St Petersburg, Florida. Dr. Walter is rated as an Advanced provider by MediFind in the treatment of Antigen-Peptide-Transporter 2 Deficiency. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Primary Immunodeficiency (PID), Infantile Neutropenia, and Common Variable Immune Deficiency. Dr. Walter is board certified in American Board Of Allergy And Immunology.
Summary: This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blin...